Dr. Raj is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Palo Alto, CA 94305Phone+1 312-908-8163Fax+1 806-743-3148
Education & Training
- Baylor College of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1999 - 2000
- Texas Tech University HSC El PasoResidency, Internal Medicine, 1996 - 1999
- Christian Medical College VelloreClass of 1995
Certifications & Licensure
- MI State Medical License 2024 - 2027
- CA State Medical License 2017 - 2025
- IL State Medical License 2012 - 2017
- TX State Medical License 2001 - 2017
- AZ State Medical License 2002 - 2006
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
- Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jul 30
Publications & Presentations
PubMed
- 1 citationsMolecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational Cohorts.Manoj V Maddali, Andrew R Moore, Pratik Sinha, Chad A Newton, John S Kim
American Journal of Respiratory and Critical Care Medicine. 2024-08-15 - 6 citationsA double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis.Matthew C Baker, Audra Horomanski, Yiwen Wang, Yuhan Liu, Shima Parsafar
Rheumatology. 2024-05-02 - 3 citationsLung function trajectories in patients with idiopathic pulmonary fibrosis.Megan L Neely, Anne S Hellkamp, Shaun Bender, Jamie L Todd, Timothy Liesching
Respiratory Research. 2023-08-24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: